|
PA-18-347: Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21 Clinical Trial Optional) |
Application Due Date(s) Cycle I Due Date February 16; Cycle II Due Date June 16; Cycle III Due Date October 16 Expiration Date January 8, 2021 |
|
PAR-18-555: Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-18-555.html |
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 8, 2021 |
|
PAR-18-554: Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-18-554.html |
Application Due Date(s) Cycle I Due Date February 16; Cycle II Due Date June 16; Cycle III Due Date October 16 Expiration Date January 8, 2021 |
|
Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) PAS-19-391: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAS-19-391.html |
Application Due Date(s) Cycle I: February 16, 2020; Cycle II: June 16, 2020; Cycle III: October 12, 2020 Expiration Date November 17, 2022
|
|
Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) PAS-19-392: Area of Focus Basic Science (R03 Clinical Trials Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAS-19-392.html |
|
|
Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) PAS-19-393: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAS-19-393.html |
|
PA-18-347: Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21 Clinical Trial Optional) |
Application Due Date(s) Cycle I Due Date February 16; Cycle II Due Date June 16; Cycle III Due Date October 16 Expiration Date January 8, 2021 |
|
PAR-18-555: Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-18-555.html |
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 8, 2021 |
|
PAR-18-554: Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-18-554.html |
Application Due Date(s) Cycle I Due Date February 16; Cycle II Due Date June 16; Cycle III Due Date October 16 Expiration Date January 8, 2021 |
|
Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) PAS-19-391: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAS-19-391.html |
Application Due Date(s) Cycle I: February 16, 2020; Cycle II: June 16, 2020; Cycle III: October 12, 2020 Expiration Date November 17, 2022
|
|
Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) PAS-19-392: Area of Focus Basic Science (R03 Clinical Trials Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAS-19-392.html |
|
|
Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) PAS-19-393: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAS-19-393.html |
|
PA-17-487: New Onset Depressive Symptoms in Acute Illness (R21 Clinical Trial Not Allowed) |
Application Due Date(s) Cycle I Due Date February 16; Cycle II Due Date June 16; Cycle III Due Date October 16 Expiration Date January 8, 2021 |
|
PA-17-488: New Onset Depressive Symptoms in Acute Illness (R01 Clinical Trial Not Allowed) |
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 8, 2021 |
|
PAR-18-941: Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-18-941.html |
Application Due Date(s) Cycle I Due Date February 16; Cycle II Due Date June 16; Cycle I Due Date October 16 Expiration Date September 8, 2021 |
|
RFA-MH-19-240: Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-240.html |
Application Due Date(s) November 20, 2020, by 5:00 PM local time of applicant organization Expiration Date November 21, 2020 |
|
PAR-18-561: NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01 Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-18-561.html |
Application Due Date(s): Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date November 6, 2020 |
|
PA-18-347: Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21 Clinical Trial Optional) |
Application Due Date(s) Cycle I Due Date February 16; Cycle II Due Date June 16; Cycle III Due Date October 16 Expiration Date January 8, 2021 |
|
RFA-EB-19-002: BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-19-002.html |
Application Due Date(s) September 3, 2021 |
|
PAR-19-171: Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAR-19-171.html |
Application Due Date(s) October 14, 2020; February 18, 2021; June 18, 2021; October 14, 2021 |
|
New: PAR-19-315: Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-19-315.html |
Letter of Intent Due Date(s): 30 days prior to the application due date Application Due Date(s) February 17, 2021; July 19, 2021; and February 14, 2022 |
|
New: PAR-19-220: Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAR-19-220.html |
Letter of Intent Due Date(s): 30 days prior to application due date. Application Due Date(s) February 17, 2021; August 18, 2021; February 16, 2022 |
|
New: RFA-NS-20-006: BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-006.html |
Letter of Intent Due Date(s) : 30 days prior to the application due date. Application Due Date(s) October 1, 2020, February 2, 2021, June 1, 2021, October 1, 2021, February 1, 2022, June 1, 2022, and October 3, 2022 |
|
New: RFA-MH-20-556: BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-556.html |
Letter of Intent Due Date(s): 30 days prior to the application due date Application Due Date(s) February 11, 2021; October 19, 2021 |
|
PAR-18-437: Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-18-437.html |
Application Due Date(s) December 18, 2020, by 5:00 PM local time of applicant organization. Expiration Date December 19, 2020 |
|
PAR-18-505: Advancing Basic Neurobiology Toward Translation Through Assay Development (R01 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAR-18-505.html |
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 8, 2021 |
|
PA-18-489: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PA-18-489.html |
Application Due Date(s) Cycle I Due Date February 16; Cycle II Due Date June 16; Cycle III Due Date October 16 Expiration Date January 8, 2021 |
|
PAR-18-550: Analytical Validation of a Candidate Biomarker for Neurological Disease (U01) (Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-18-550.html |
Application Due Date(s) July 20, 2020, by 5:00 PM local time of applicant organization. Expiration Date September 8, 2020 |
|
PAR-18-528: NeuroNEXT Clinical Trials (U01 Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-18-528.html |
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June; Cycle III Due Date October 5 Expiration Date January 8, 2021 |
|
Postdoctoral Individual National Research Service Award PAR-20-021: NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAR-20-021.html |
Application Due Date(s) June 9, 2020, and October 14, 2020, February 11, 2021, June 9, 2021, October 14, 2021, February 9, 2022, June 8, 2022, and October 11, 2022. Expiration Date January 8, 2023 |
|
RFA-NS-18-020: BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-020.html |
Application Due Date(s) October 29, 2020 |
|
PAR-18-530: Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-18-530.html |
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 8, 2021 |
|
PAR-18-433: NIBIB Exploratory/Developmental Research Grant Program (R21 Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-18-433.html |
Application Due Date(s) Cycle I Due Date February 16; Cycle II Due Date June 16; Cycle III Due Date October 16 Expiration Date January 8, 2021 |
|
New: PAR-20-122: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAR-20-122.html |
Letter of Intent Due Date(s): 30 days prior to the application due date Application Due Date(s): February 9, 2021, August 10, 2021, February 9, 2022 August 9, 2022, February 9, 2023 |
|
New: PAR-20-082: Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAR-20-082.html |
Application Due Date(s): Cycle I Due Date February 16; Cycle II Due Date June 16; Cycle I Due Date October 16 Expiration Date January 08, 2023 |
|
New: PAR-20-055: Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) This FOA is intended to provide support for the further development of projects where preliminary data supports the feasibility of the line of investigation. https://grants.nih.gov/grants/guide/pa-files/PAR-20-055.html |
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 08, 2023 |
|
PAS-18-483: Promoting Research in Basic Neuroscience (R01 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAS-18-483.html |
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 8, 2021 |
|
PA-18-488: NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
Application Due Date(s) Cycle I Due Date February 16; Cycle II Due Date June 16; Cycle III Due Date October 16 Expiration Date January 8, 2021 |
|
PA-18-484: NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 8, 2021 |
|
PA-18-358: NINDS Exploratory Neuroscience Research Grant (R21- Clinical Trial Optional) |
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 8, 2022 |
|
PAR-19-158: Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAR-19-158.html
|
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 8, 2022 |
|
PA-19-091: NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) https://grants.nih.gov/grants/guide/pa-files/PA-19-091.html
|
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 8, 2022 |
|
PA-19-056: NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
Application Due Date(s) Cycle I Due Date February 5; Cycle II Due Date June 5; Cycle III Due Date October 5 Expiration Date January 8, 2022 |
NIH Funding Opportunities (Foreign Institutions are eligible to apply)
More information on the page Funding opportunities
This part of the website could either be in French or English, depending on the sources of the actualities.